Clinical significance of persistent left superior vena cava diagnosed in fetal life.
- Author:
Jin Kyong LEE
1
;
Hye Sung WON
;
Sang Hun LEE
;
So Hee LIM
;
Min Gyun KIM
;
Jae Yoon SHIM
;
Pil Ryang LEE
;
Ahm KIM
Author Information
1. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea. hswon@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
PLSVC;
Congenital heart disease;
Prenatal diagnosis;
Pregnancy outcomes
- MeSH:
Echocardiography;
Female;
Fetus;
Follow-Up Studies;
Glycosaminoglycans;
Heart;
Heterotaxy Syndrome;
Humans;
Infant;
Interviews as Topic;
Isomerism;
Live Birth;
Lost to Follow-Up;
Parturition;
Pregnancy;
Pregnancy Outcome;
Prenatal Diagnosis;
Pulmonary Artery;
Retrospective Studies;
Scimitar Syndrome;
Ultrasonography, Prenatal;
Vascular Malformations;
Vena Cava, Superior
- From:Korean Journal of Obstetrics and Gynecology
2009;52(10):1000-1006
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To determine the clinical significance of persistent left superior vena cava (PLSVC) in a fetus with and without cardiac and extra-cardiac anomalies. METHODS: This was a retrospective review of all cases of PLSVC detected prenatally at our institution between May 2001 and May 2008. This retrospective study included 85 fetuses with PLSVC who were diagnosed based on the presence of an additional vessel identified to the left of the pulmonary artery in the three-vessel view of the heart. Patient charts and recorded images were reviewed in order to identify associated conditions and outcomes. Telephone interviews were conducted to check patients' conditions in cases of isolated PLSVC. RESULTS: Eighty-five cases of PLSVC were detected prenatally during this study period. Of these 85 fetuses, 11 were aborted due to associated, prenatally proven, severe congenital heart anomalies or chromosomal anomalies, and 52 fetuses were delivered. The cases for other 22 fetuses were lost to follow-up. Postnatal echocardiography was performed in the 33, surviving patients, and PLSVC was confirmed in 32 of these patients. The most common associated congenital cardiac anomalies were seen included VSD, AVSD, and DORV (54.1%, 17.6% and 17.6%, respectively) (Table 3). PLSVC was also seen in seven cases (8.2%) of right isomerism and in four cases (4.7%) of left isomerism. In only two cases was the coexistence of PLSVC and extra-cardiac anomalies noted in this study. Fifteen cases were prenatally diagnosed as isolated PLSVC and all of them had live births. The follow-up period in our isolated PLSVC patients ranged from 0.5 to 84 months (Mean 24.5 months). Thirteen of these infants were doing well at the time of preparing this document and one case was diagnosed as TAPVR on postnatal echocardiography and one case was lost to follow-up. CONCLUSION: We strongly suggest that PLSVC is a benign vascular malformation and does not affect to the patient after birth. However, PLSVC is frequently associated with heterotaxy syndromes as well as other cardiac malformations and can be misdiagnosed as TAPVR. So if we find PLSVC in prenatal ultrasonography, meticulous inspection of the fetal anatomy must be performed.
